Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis
United European Gastroenterology Journal · 2023
DOI: 10.1002/ueg2.12369 ↗Kurz gefasst
Fachartikel in der Zeitschrift United European Gastroenterology Journal, 2023. Verfasst von Antonio Tursi und 43 weiteren Autor:innen. Beteiligte Einrichtung: Territorial Gastroenterology Service, ASL BAT, Andria, Barletta-Andria-Trani, Italy. Hauptthemen laut MEDLINE: Diverticulosis, Colonic, Diverticular Diseases, Diverticulum. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Aims The Diverticular Inflammation and Complication Assessment (DICA) classification and the Combined Overview on Diverticular Assessment (CODA) were found to be effective in predicting the outcomes of Diverticular Disease (DD). We ascertain whether fecal calprotectin (FC) can further aid in improving risk stratification.
Methods
A three‐year international, multicentre, prospective cohort study was conducted involving 43 Gastroenterology and Endoscopy centres. Survival methods for censored observations were used to estimate the risk of acute diverticulitis (AD) in newly diagnosed DD patients according to basal FC, DICA, and CODA. The net benefit of management strategies based on DICA, CODA and FC in addition to CODA was assessed with decision curve analysis, which incorporates the harms and benefits of using a prognostic model for clinical decisions.
Results
At the first diagnosis of diverticulosis/DD, 871 participants underwent FC measurement. FC was associated with the risk of AD at 3 years (HR per each base 10 logarithm increase: 3.29; 95% confidence interval, 2.13–5.10) and showed moderate discrimination (c‐statistic: 0.685; 0.614–0.756). DICA and CODA were more accurate predictors of AD than FC. However, FC showed high discrimination capacity to predict AD at 3 months, which was not maintained at longer follow‐up times. The decision curve analysis comparing the combination of FC and CODA with CODA alone did not clearly indicate a larger net benefit of one strategy over the other.
Conclusions
FC measurement could be used as a complementary tool to assess the immediate risk of AD. In all other cases, treatment strategies based on the CODA score alone should be recommended.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Territorial Gastroenterology Service, ASL BAT, Andria, Barletta-Andria-Trani, Italy.
- Department of Medical and Surgical Sciences, Post-graduate School of Digestive Diseases, Catholic University, Rome, Italy.
- Department of Biomedical Sciences, Humanitas University, Milan, Italy.
- IRCCS Humanitas Research Hospital, Milan, Italy.
- Division of Internal Medicine and Gastroenterology, "Cristo Re" Hospital, Rome, Italy.
- Department of Medical and Surgical Sciences, Gastroenterology Unit, University of Parma, Parma, Italy.
ORCID-Profile: Antonio Tursi, Gabrio Bassotti, Alfredo Papa, Stefano Pontone, Matthias Christian Reichert, Jaroslaw Regula, Franco Scaldaferri, Stefanos Bonovas, Silvio Danese
Zitieren
APA
Tursi, A., Piovani, D., Brandimarte, G., Di Mario, F., Elisei, W., Picchio, M., Allegretta, L., Annunziata, M. L., Bafutto, M., Bassotti, G., Bianco, M. A., Colucci, R., Conigliaro, R., Dumitrascu, D. L., Escalante, R., Ferrini, L., Forti, G., Franceschi, M., Graziani, M. G., …, & DICA International Group (2023). Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.12369
Vancouver
Tursi A, Piovani D, Brandimarte G, Di Mario F, Elisei W, Picchio M, et al. Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis. United European Gastroenterology Journal. 2023. doi:10.1002/ueg2.12369
BibTeX
@article{Tursi2023,
author = {Tursi, Antonio and Piovani, Daniele and Brandimarte, Giovanni and Di Mario, Francesco and Elisei, Walter and Picchio, Marcello and Allegretta, Leonardo and Annunziata, Maria Laura and Bafutto, Mauro and Bassotti, Gabrio and Bianco, Maria Antonia and Colucci, Raffaele and Conigliaro, Rita and Dumitrascu, Dan L and Escalante, Ricardo and Ferrini, Luciano and Forti, Giacomo and Franceschi, Marilisa and Graziani, Maria Giovanna and Lammert, Frank and Latella, Giovanni and Maconi, Giovanni and Compare, Debora and Nardone, Gerardo and Camara De Castro Oliveira, Lucia and Oliveira, Enio Chaves and Papa, Alfredo and Papagrigoriadis, Savvas and Pietrzak, Anna and Pontone, Stefano and Poskus, Tomas and Pranzo, Giuseppe and Reichert, Matthias Christian and Rodinò, Stefano and Regula, Jaroslaw and Scaccianoce, Giuseppe and Scaldaferri, Franco and Vassallo, Roberto and Zampaletta, Costantino and Zullo, Angelo and Spaziani, Erasmo and Bonovas, Stefanos and Danese, Silvio and DICA International Group, DICA International Group},
title = {Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis},
journal = {United European Gastroenterology Journal},
year = {2023},
doi = {10.1002/ueg2.12369}
}
EUVIMED